[HTML][HTML] A short review on antibody therapy for COVID-19
GV Kumar, V Jeyanthi, S Ramakrishnan - New microbes and new infections, 2020 - Elsevier
The beginning of the novel SARS-CoV-2 human coronavirus in Wuhan, China, has triggered
a worldwide respiratory disease outbreak (COVID-19). By April 07, 2020, SARS-CoV-2 has
affected more than 1.36 million people worldwide and caused more than 75,900 deaths. To
date, the anti-malaria drug hydroxychloroquine found to be a treatment option for SARS-CoV-
2. In addition to supportive treatment, such as oxygen supply in moderate cases and
extracorporeal membrane oxygenation in critically ill patients, unique medications for this …
a worldwide respiratory disease outbreak (COVID-19). By April 07, 2020, SARS-CoV-2 has
affected more than 1.36 million people worldwide and caused more than 75,900 deaths. To
date, the anti-malaria drug hydroxychloroquine found to be a treatment option for SARS-CoV-
2. In addition to supportive treatment, such as oxygen supply in moderate cases and
extracorporeal membrane oxygenation in critically ill patients, unique medications for this …
以上显示的是最相近的搜索结果。 查看全部搜索结果